Selected research
Market Structure
Global Anxiety Relief Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anxiety Relief Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anxiety Relief Supplements include LONZA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Nestle S.A., Merck, The Nature's Bounty Co., Now Food, Nature's Sunshine and Herbalife, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anxiety Relief Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anxiety Relief Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anxiety Relief Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anxiety Relief Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Anxiety Relief Supplements Segment by Company
LONZA
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Nestle S.A.
Merck
The Nature's Bounty Co.
Now Food
Nature's Sunshine
Herbalife
GNC
DuPont
DSM
Ayanda
Arkopharma
Amway Corporation
Abbott Laboratories
Anxiety Relief Supplements Segment by Type
Vitamin Supplements
Magnesium Supplements
L-Theanine Supplements
Other
Anxiety Relief Supplements Segment by Application
Clinic
Pharmacy
E-commerce Platform
Supermarket
Other
Anxiety Relief Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Relief Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anxiety Relief Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Relief Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anxiety Relief Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anxiety Relief Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anxiety Relief Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anxiety Relief Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamin Supplements
- Magnesium Supplements
- L-Theanine Supplements
- Other
Applications
- Clinic
- Pharmacy
- E-commerce Platform
- Supermarket
- Other
Companies covered
- LONZA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Nestle S.A.
- Merck
- The Nature's Bounty Co.
- Now Food
- Nature's Sunshine
- Herbalife
- GNC
- DuPont
- DSM
- Ayanda
- Arkopharma
- Amway Corporation
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anxiety Relief Supplements Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anxiety Relief Supplements Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anxiety Relief Supplements Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anxiety Relief Supplements Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anxiety Relief Supplements Market Dynamics
- 2.1 Anxiety Relief Supplements Industry Trends
- 2.2 Anxiety Relief Supplements Industry Drivers
- 2.3 Anxiety Relief Supplements Industry Opportunities and Challenges
- 2.4 Anxiety Relief Supplements Industry Restraints
3 Anxiety Relief Supplements Market by Manufacturers
- 3.1 Global Anxiety Relief Supplements Revenue by Manufacturers (2021-2026)
- 3.2 Global Anxiety Relief Supplements Sales by Manufacturers (2021-2026)
- 3.3 Global Anxiety Relief Supplements Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anxiety Relief Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anxiety Relief Supplements Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anxiety Relief Supplements Manufacturers, Product Type & Application
- 3.7 Global Anxiety Relief Supplements Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anxiety Relief Supplements Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anxiety Relief Supplements Players Market Share by Revenue in 2025
- 3.8.3 2025 Anxiety Relief Supplements Tier 1, Tier 2, and Tier 3
4 Anxiety Relief Supplements Market by Type
- 4.1 Anxiety Relief Supplements Type Introduction
- 4.1.1 Vitamin Supplements
- 4.1.2 Magnesium Supplements
- 4.1.3 L-Theanine Supplements
- 4.1.4 Other
- 4.2 Global Anxiety Relief Supplements Sales by Type
- 4.2.1 Global Anxiety Relief Supplements Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anxiety Relief Supplements Sales by Type (2021-2032)
- 4.2.3 Global Anxiety Relief Supplements Sales Market Share by Type (2021-2032)
- 4.3 Global Anxiety Relief Supplements Revenue by Type
- 4.3.1 Global Anxiety Relief Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anxiety Relief Supplements Revenue by Type (2021-2032)
- 4.3.3 Global Anxiety Relief Supplements Revenue Market Share by Type (2021-2032)
5 Anxiety Relief Supplements Market by Application
- 5.1 Anxiety Relief Supplements Application Introduction
- 5.1.1 Clinic
- 5.1.2 Pharmacy
- 5.1.3 E-commerce Platform
- 5.1.4 Supermarket
- 5.1.5 Other
- 5.2 Global Anxiety Relief Supplements Sales by Application
- 5.2.1 Global Anxiety Relief Supplements Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anxiety Relief Supplements Sales by Application (2021-2032)
- 5.2.3 Global Anxiety Relief Supplements Sales Market Share by Application (2021-2032)
- 5.3 Global Anxiety Relief Supplements Revenue by Application
- 5.3.1 Global Anxiety Relief Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anxiety Relief Supplements Revenue by Application (2021-2032)
- 5.3.3 Global Anxiety Relief Supplements Revenue Market Share by Application (2021-2032)
6 Global Anxiety Relief Supplements Sales by Region
- 6.1 Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anxiety Relief Supplements Sales by Region (2021-2032)
- 6.2.1 Global Anxiety Relief Supplements Sales by Region (2021-2026)
- 6.2.2 Global Anxiety Relief Supplements Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anxiety Relief Supplements Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anxiety Relief Supplements Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anxiety Relief Supplements Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anxiety Relief Supplements Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anxiety Relief Supplements Revenue by Region
- 7.1 Global Anxiety Relief Supplements Revenue by Region
- 7.1.1 Global Anxiety Relief Supplements Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anxiety Relief Supplements Revenue by Region (2021-2026)
- 7.1.3 Global Anxiety Relief Supplements Revenue by Region (2027-2032)
- 7.1.4 Global Anxiety Relief Supplements Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anxiety Relief Supplements Revenue (2021-2032)
- 7.2.2 North America Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anxiety Relief Supplements Revenue (2021-2032)
- 7.3.2 Europe Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anxiety Relief Supplements Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anxiety Relief Supplements Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 LONZA
- 8.1.1 LONZA Company Information
- 8.1.2 LONZA Business Overview
- 8.1.3 LONZA Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 LONZA Anxiety Relief Supplements Product Portfolio
- 8.1.5 LONZA Recent Developments
- 8.2 Takeda Pharmaceutical Co. Ltd.
- 8.2.1 Takeda Pharmaceutical Co. Ltd. Company Information
- 8.2.2 Takeda Pharmaceutical Co. Ltd. Business Overview
- 8.2.3 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio
- 8.2.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
- 8.3 Teva Pharmaceutical Industries Ltd.
- 8.3.1 Teva Pharmaceutical Industries Ltd. Company Information
- 8.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 8.3.3 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio
- 8.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 8.4 Nestle S.A.
- 8.4.1 Nestle S.A. Company Information
- 8.4.2 Nestle S.A. Business Overview
- 8.4.3 Nestle S.A. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Nestle S.A. Anxiety Relief Supplements Product Portfolio
- 8.4.5 Nestle S.A. Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Anxiety Relief Supplements Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 The Nature's Bounty Co.
- 8.6.1 The Nature's Bounty Co. Company Information
- 8.6.2 The Nature's Bounty Co. Business Overview
- 8.6.3 The Nature's Bounty Co. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio
- 8.6.5 The Nature's Bounty Co. Recent Developments
- 8.7 Now Food
- 8.7.1 Now Food Company Information
- 8.7.2 Now Food Business Overview
- 8.7.3 Now Food Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Now Food Anxiety Relief Supplements Product Portfolio
- 8.7.5 Now Food Recent Developments
- 8.8 Nature's Sunshine
- 8.8.1 Nature's Sunshine Company Information
- 8.8.2 Nature's Sunshine Business Overview
- 8.8.3 Nature's Sunshine Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nature's Sunshine Anxiety Relief Supplements Product Portfolio
- 8.8.5 Nature's Sunshine Recent Developments
- 8.9 Herbalife
- 8.9.1 Herbalife Company Information
- 8.9.2 Herbalife Business Overview
- 8.9.3 Herbalife Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Herbalife Anxiety Relief Supplements Product Portfolio
- 8.9.5 Herbalife Recent Developments
- 8.10 GNC
- 8.10.1 GNC Company Information
- 8.10.2 GNC Business Overview
- 8.10.3 GNC Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 GNC Anxiety Relief Supplements Product Portfolio
- 8.10.5 GNC Recent Developments
- 8.11 DuPont
- 8.11.1 DuPont Company Information
- 8.11.2 DuPont Business Overview
- 8.11.3 DuPont Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 DuPont Anxiety Relief Supplements Product Portfolio
- 8.11.5 DuPont Recent Developments
- 8.12 DSM
- 8.12.1 DSM Company Information
- 8.12.2 DSM Business Overview
- 8.12.3 DSM Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 DSM Anxiety Relief Supplements Product Portfolio
- 8.12.5 DSM Recent Developments
- 8.13 Ayanda
- 8.13.1 Ayanda Company Information
- 8.13.2 Ayanda Business Overview
- 8.13.3 Ayanda Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Ayanda Anxiety Relief Supplements Product Portfolio
- 8.13.5 Ayanda Recent Developments
- 8.14 Arkopharma
- 8.14.1 Arkopharma Company Information
- 8.14.2 Arkopharma Business Overview
- 8.14.3 Arkopharma Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Arkopharma Anxiety Relief Supplements Product Portfolio
- 8.14.5 Arkopharma Recent Developments
- 8.15 Amway Corporation
- 8.15.1 Amway Corporation Company Information
- 8.15.2 Amway Corporation Business Overview
- 8.15.3 Amway Corporation Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Amway Corporation Anxiety Relief Supplements Product Portfolio
- 8.15.5 Amway Corporation Recent Developments
- 8.16 Abbott Laboratories
- 8.16.1 Abbott Laboratories Company Information
- 8.16.2 Abbott Laboratories Business Overview
- 8.16.3 Abbott Laboratories Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Abbott Laboratories Anxiety Relief Supplements Product Portfolio
- 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anxiety Relief Supplements Value Chain Analysis
- 9.1.1 Anxiety Relief Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anxiety Relief Supplements Production Mode & Process
- 9.2 Anxiety Relief Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anxiety Relief Supplements Distributors
- 9.2.3 Anxiety Relief Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst